Skip to main content
OpenTrials

Clinical trial condition

Prolymphocytic Leukemia

Explore clinical trials studying Prolymphocytic Leukemia. Study availability and eligibility vary by location and protocol.

44 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Prolymphocytic Leukemia trial results

Active, Not Recruiting

ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (BTK) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia, Richter's Syndrome or Prolymphocytic Leukemia

NCT02029443

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site New Hyde Park, New York, United States
  • Research Site New York, United States
  • Research Site Columbus, Ohio, United States
View Trial Details

Related conditions